Alerta De Seguridad para Transverse connector, micro-wound, 190 mm (Registration - STRASBOURG STRATOS OSTEOSYNTHESIS SYSTEM, Registration no. 10369290036 - Code 01410190 - batches under risk: 2011003417; 2010004014

Según Agência Nacional de Vigilância Sanitária (ANVISA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Brazil que fue producido por Orcimed Industria e Comercio Ltda.; MedXpert GmbH.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
  • Fecha
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notas adicionales en la data
    According to the manifestation of the company, the various indications for the use of Stratos implants result in very different mechanical load characteristics. There are also factors that exert an unpredictable influence, conditioned by the patient's lifestyle after the surgery, by observing the physician's indications and by the patient's collaboration. Implants only fulfill their mission until the healing and healing of bones is complete. After that, they no longer have mechanical function, being considered foreign bodies for the locomotor system. Especially in retrosternal implantation (pectus excavatum), the risk of rupture of isolated implants presents an increased risk for the patient. It also indicates that the risk assessment is essential for the doctor. #### UPDATED ON 08/18/2017, the field action documentations submitted by the company are filed in the area. If necessary, the area can reassess the action at any time.
  • Causa
    The manufacturer of the product evaluated the possibility of rupture of the transverse rods / connectors of the stratos system in patients operated for more than 18 months to correct pectus escavatum with the ravich technique. the company received adverse event notification (implant break) in a patient operated for more than two years. as a result of the research process the product failure was attributed to the implant capacity overload.
  • Acción
    The company that registers in Brazil advises that implants should be removed approximately 12 to 18 months postoperatively. In all cases, postoperative monitoring of the patient is mandatory. It is recommended that patients be examined at appropriate intervals (all 4 to 6 months). In all post-operative examinations, chest x-rays should be taken at two levels to check if the reconstruction is intact. The decision on the removal of the implant and the time of execution should be evaluated on a case-by-case basis, according to the extent, location and possible discomfort of the patient.